Bentham Science Logo

Track Your Manuscript:

Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access


Current Cancer Drug Targets, Volume 15 - Number 6

Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety

, 15(6): 452 - 462

Saїd C. Azoury, David M. Straughan and Vivek Shukla

DOI: 10.2174/156800961506150805145120

Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas

, 15(6): 463 - 468

Marc Giry-Laterriere, Andreia V. Pinho, Nils Eling, Lorraine Chantrill and Ilse Rooman

DOI: 10.2174/1568009615666150512102957

Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer

, 15(6): 469 - 480

Lewis Quayle, Penelope D. Ottewell and Ingunn Holen

DOI: 10.2174/1568009615666150506092443

Extracellular Ca2+ Selectively Enhances Adriamycin-induced Cell Death in Human Hepatoma Cells

, 15(6): 481 - 492

Xuexue Huang, Yuan Xu, Yanyi Liu, Hong Xie, Jiachun Wang and Zhigang Wu

DOI: 10.2174/156800961506150805151905

A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor

, 15(6): 493 - 503

Yin Li, Kai Chen, Yong Zhou, Yiren Xiao, Manman Deng, Zhiwu Jiang, Wei Ye, Xiangmeng Wang, Xinru Wei, Jie Li, Jiabao Liang, Zhongxin Zheng, Yao Yao, Weiguang Wang, Peng Li and Bing Xu

DOI: 10.2174/156800961506150805153230

11-Phenylundeca-5Z,9Z-dienoic Acid: Stereoselective Synthesis and Dual Topoisomerase I/IIα Inhibition

, 15(6): 504 - 510

Vladimir A. D’yakonov, Lilya U. Dzhemileva, Aleksey A. Makarov, Alfiya R. Mulyukova, Dmitry S. Baevd, Elza K. Khusnutdinova, Tatiana G. Tolstikova and Usein M. Dzhemilev

DOI: 10.2174/1568009615666150506093155

The Prognosis of Patients with Liver Metastases from Colorectal Cancer still Depends on Anatomical Presentation more than on Treatments

, 15(6): 511 - 518

Paolo G. Gobbi, Sandro Rossi, Mario Comelli, Valentina Ravetta, Laura L. Rosa, Silvia Brugnatelli, Franco Corbella, Sara Delfanti, Islam Abumalouh and Paolo Dionigi

DOI: 10.2174/1568009615666150508094824

CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription

, 15(6): 519 - 532

Zanxian Xia, Mingquan Guo, Han Liu, Luwei Jiang, Qiaoxia Li, Jian Peng, Jia-Da Li, Baoen Shan, Pinghui Feng and Hong Ma

DOI: 10.2174/1568009615666150506093643


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.



Related Journals

Related eBooks

eBooks Catalog